These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 14986014)

  • 1. Glucocorticoid use represents a risk factor for central serous chorioretinopathy: a prospective, case-control study.
    Karadimas P; Bouzas EA
    Graefes Arch Clin Exp Ophthalmol; 2004 Sep; 242(9):800-2. PubMed ID: 14986014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrotic scar formation in central serous chorioretinopathy developed during systemic treatment with corticosteroids.
    Hooymans JM
    Graefes Arch Clin Exp Ophthalmol; 1998 Nov; 236(11):876-9. PubMed ID: 9825265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central serous chorioretinopathy and glucocorticoids.
    Bouzas EA; Karadimas P; Pournaras CJ
    Surv Ophthalmol; 2002; 47(5):431-48. PubMed ID: 12431693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Central serous chorioretinopathy as a complication of epitheliopathy under treatment with glucocorticoids].
    Fernández Hortelano A; Sádaba LM; Heras Mulero H; García Layana A
    Arch Soc Esp Oftalmol; 2005 Apr; 80(4):255-8. PubMed ID: 15852168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central serous chorioretinopathy complicating systemic corticosteroid therapy.
    Abu el-Asrar AM
    Eur J Ophthalmol; 1997; 7(3):297-300. PubMed ID: 9352287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The adverse effects of corticosteroids in central serous chorioretinopathy.
    De Nijs E; Brabant P; De Laey JJ
    Bull Soc Belge Ophtalmol; 2003; (289):35-41. PubMed ID: 14619628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central serous chorioretinopathy complicating solar retinopathy treated with glucocorticoids.
    Bouzas EA; Moret P; Pournaras CJ
    Graefes Arch Clin Exp Ophthalmol; 1999 Feb; 237(2):166-8. PubMed ID: 9987635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic findings associated with central serous chorioretinopathy.
    Tittl MK; Spaide RF; Wong D; Pilotto E; Yannuzzi LA; Fisher YL; Freund B; Guyer DR; Slakter JS; Sorenson JA
    Am J Ophthalmol; 1999 Jul; 128(1):63-8. PubMed ID: 10482095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seventeen cases of central serous chorioretinopathy associated with systemic corticosteroid therapy.
    Koyama M; Mizota A; Igarashi Y; Adachi-Usami E
    Ophthalmologica; 2004; 218(2):107-10. PubMed ID: 15004499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central serous chorioretinopathy as a complication of postcardiac transplant corticosteroid therapy.
    Singh AD; Demirci H; Shields CL; Shields JA
    Eye (Lond); 2003 May; 17(4):522-4. PubMed ID: 12802354
    [No Abstract]   [Full Text] [Related]  

  • 11. Central serous chorioretinopathy in patients receiving systemic corticosteroid therapy.
    Levy J; Marcus M; Belfair N; Klemperer I; Lifshitz T
    Can J Ophthalmol; 2005 Apr; 40(2):217-21. PubMed ID: 16049541
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute bilateral central serous chorioretinopathy following intra-articular injection of corticosteroid.
    Mondal LK; Sarkar K; Datta H; Chatterjee PR
    Indian J Ophthalmol; 2005 Jun; 53(2):132-4. PubMed ID: 15976473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An unusual case of central serous chorioretinopathy in a patient with acute retinal necrosis.
    Stuebiger N; Biester S; Deuter CM; Zierhut M
    Ocul Immunol Inflamm; 2008; 16(3):109-11. PubMed ID: 18569799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of central serous chorioretinopathy in adults prescribed oral corticosteroids: a population-based study in Taiwan.
    Tsai DC; Chen SJ; Huang CC; Chou P; Chung CM; Chan WL; Huang PH; Lin SJ; Chen JW; Chen TJ; Leu HB
    Retina; 2014 Sep; 34(9):1867-74. PubMed ID: 24743638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural course of central serous chorioretinopathy without subretinal exudates in normal pregnancy.
    Al-Mujaini A; Wali U; Ganesh A; Montana C
    Can J Ophthalmol; 2008 Oct; 43(5):588-90. PubMed ID: 18982038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shift Work: A Risk Factor for Central Serous Chorioretinopathy.
    Bousquet E; Dhundass M; Lehmann M; Rothschild PR; Bayon V; Leger D; Bergin C; Dirani A; Beydoun T; Behar-Cohen F
    Am J Ophthalmol; 2016 May; 165():23-8. PubMed ID: 26915576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central serous chorioretinopathy after local application of glucocorticoids for skin disorders.
    Karadimas P; Kapetanios A; Bouzas EA
    Arch Ophthalmol; 2004 May; 122(5):784-6. PubMed ID: 15136332
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk factors for central serous chorioretinopathy: a case-control study.
    Haimovici R; Koh S; Gagnon DR; Lehrfeld T; Wellik S;
    Ophthalmology; 2004 Feb; 111(2):244-9. PubMed ID: 15019370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bilateral central serous chorioretinopathy caused by intranasal corticosteroids: a case report and review of the literature.
    Kleinberger AJ; Patel C; Lieberman RM; Malkin BD
    Laryngoscope; 2011 Sep; 121(9):2034-7. PubMed ID: 22024860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticosteroid-induced central serous chorioretinopathy.
    Wakakura M; Song E; Ishikawa S
    Jpn J Ophthalmol; 1997; 41(3):180-5. PubMed ID: 9243315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.